Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Gary Barker

Gary Barker, Partner/Owner, Eye Associates Of Winter ParkPartner/Owner
Eye Associates Of Winter Park
Member of the Healthcare Council

Gary Barker, OD, FAAO, is a Partner and Co-Founder of the group practice Eye Associates of Winter Park, Florida. Dr. Barker is the Past-President of the Florida Optometric Association, where he remains active in legislative affairs. Clinically, he has participated in numerous Phase III FDA studies of new contact lenses and contact lens solutions. Dr. Barker is very familiar with all types of contact lenses and contact lens care systems, and stays aware of trends in the contact lens market. Dr. Barker diagnoses and treats eye disease, including glaucoma. (This is me - Update Profile)


Employment History
1985 - present Partner/Owner
Eye Associates Of Winter Park
1983 - 1984 Examiner, Early Treatment of Diabetic Retinopathy
University of Texas Health Science Center

GLG NewsSM Analyses by Gary Barker(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Is LASIK the issue or is choosing the right refractive surgery for the right patient the real issue? | 05-07-2008
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: Gary Barker, Partner/Owner, Eye Associates Of Winter Park

I welcome the FDA investigation of LASIK, as thousands of patients are undergoing the elective cosmetic procedure, with some achieving less than optimum results.  Will the study show that LASIK is not safe, or will it show that LASIK is not the real issue, rather that patient selection is...

Injectable glaucoma drug vs. patient compliance | 04-15-2008
Author: Gary Barker, Partner/Owner, Eye Associates Of Winter Park

Any new efficacious glaucoma treatment is welcome and needed, but patient compliance remains a factor.  A single injection treatment that provides IOP reduction for 3 months would greatly improve success in IOP control.  I would, however, like to see a lower target pressure set for the...

Novartis grabs a winner | 04-15-2008
Author: Gary Barker, Partner/Owner, Eye Associates Of Winter Park

The purchase of a controlling interest in Alcon by Novartis is a brilliant move by Novartis.  To bring the leading contact lens disinfectant together with Ciba's contact lenses is a wonderful marketing opportunity for Ciba.

Neuroprotection is the Key in Glaucoma Treatment | 10-07-2007
Analysis of: Targeting amyloid- b in Glaucoma | www.pnas.org
Author: Gary Barker, Partner/Owner, Eye Associates Of Winter Park

To delve further into the reasons for retinal ganglion cell death is critical for the future of glaucoma treatment. As the article discusses, there are reasons for retinal ganglion cell death other than high intraocular pressures.  Unfortunately, the only medical and surgical methods we have...

View All GLG News SM Analyses by Gary Barker

GLG InstituteSM Seminars with Gary Barker(?)

 
Gary Barker has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Gary Barker









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics